High affinity, developability and functional size: the holy grail of combinatorial antibody library generation
- PMID: 21540796
- PMCID: PMC6263270
- DOI: 10.3390/molecules16053675
High affinity, developability and functional size: the holy grail of combinatorial antibody library generation
Abstract
Since the initial description of phage display technology for the generation of human antibodies, a variety of selection methods has been developed. The most critical parameter for all in vitro-based approaches is the quality of the antibody library. Concurrent evolution of the libraries has allowed display and selection technologies to reveal their full potential. They come in different flavors, from naïve to fully synthetic and differ in terms of size, quality, method of preparation, framework and CDR composition. Early on, the focus has mainly been on affinities and thus on library size and diversity. Subsequently, the increased awareness of developability and cost of goods as important success factors has spurred efforts to generate libraries with improved biophysical properties and favorable production characteristics. More recently a major focus on reduction of unwanted side effects through reduced immunogenicity and improved overall biophysical behavior has led to a re-evaluation of library design.
Figures
Similar articles
-
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries.MAbs. 2021 Jan-Dec;13(1):1980942. doi: 10.1080/19420862.2021.1980942. MAbs. 2021. PMID: 34850665 Free PMC article.
-
Generation and analysis of the improved human HAL9/10 antibody phage display libraries.BMC Biotechnol. 2015 Feb 19;15:10. doi: 10.1186/s12896-015-0125-0. BMC Biotechnol. 2015. PMID: 25888378 Free PMC article.
-
High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.J Mol Biol. 2007 Nov 2;373(4):924-40. doi: 10.1016/j.jmb.2007.08.005. Epub 2007 Aug 19. J Mol Biol. 2007. PMID: 17825836
-
Therapeutic Antibodies by Phage Display.Curr Pharm Des. 2016;22(43):6538-6559. doi: 10.2174/1381612822666160923113714. Curr Pharm Des. 2016. PMID: 27669967 Review.
-
Phage Display Libraries for Antibody Therapeutic Discovery and Development.Antibodies (Basel). 2019 Aug 23;8(3):44. doi: 10.3390/antib8030044. Antibodies (Basel). 2019. PMID: 31544850 Free PMC article. Review.
Cited by
-
Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment.Front Oncol. 2023 Nov 3;13:1275076. doi: 10.3389/fonc.2023.1275076. eCollection 2023. Front Oncol. 2023. PMID: 38023191 Free PMC article. Review.
-
Computational design of novel nanobodies targeting the receptor binding domain of variants of concern of SARS-CoV-2.PLoS One. 2023 Oct 24;18(10):e0293263. doi: 10.1371/journal.pone.0293263. eCollection 2023. PLoS One. 2023. PMID: 37874836 Free PMC article.
-
Recent advances in the development of therapeutic peptides.Trends Pharmacol Sci. 2023 Jul;44(7):425-441. doi: 10.1016/j.tips.2023.04.003. Epub 2023 May 27. Trends Pharmacol Sci. 2023. PMID: 37246037 Review.
-
Highly reliable GIGA-sized synthetic human therapeutic antibody library construction.Front Immunol. 2023 Apr 27;14:1089395. doi: 10.3389/fimmu.2023.1089395. eCollection 2023. Front Immunol. 2023. PMID: 37180155 Free PMC article.
-
Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases.Nat Rev Chem. 2021 Apr;5(4):277-294. doi: 10.1038/s41570-021-00254-9. Epub 2021 Feb 15. Nat Rev Chem. 2021. PMID: 37117282 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
